FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2010/091/006091 [Registered on: 11/01/2011]
Last Modified On: 09/10/2014
Post Graduate Thesis   
Type of Trial   
Type of Study    
Study Design  Randomized, Parallel Group, Active Controlled Trial 
Public Title of Study
Modification(s)  
A clinical trial to study of two drugs, ketamine and s-ketamine in surgeries for lower abdomen or other lower extremities. 
Scientific Title of Study
Modification(s)  
A double blind randomized comparative controlled study of efficacy and duration of analgesia for Intrathecal Ketamine & S-Ketamine in Surgeries for Lower Abdomen or other Lower Extremities  
Trial Acronym  KPS Clinical Services Pvt. Ltd. 
Secondary IDs if Any
Modification(s)  
Secondary ID  Identifier 
Naprod/CT/S-ketamine/102010,version noIND/10/V.1  Protocol Number 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr. Balmiki Sharma 
Designation   
Affiliation   
Address  Medical officer incharge
Primary Health Center
Not Applicable
N/A
852125
India 
Phone  9939222010  
Fax    
Email  drbalmikisharma@gmail.com  
 
Details of Contact Person
Scientific Query

Modification(s)  
Name  Mr Abinash Kumar 
Designation   
Affiliation   
Address  Project Manager
KPS Clinical Services Pvt. Ltd
Not Applicable
N/A
201306
India 
Phone  9654200570  
Fax  01204213840  
Email  abinash@kpsclin.com  
 
Details of Contact Person
Public Query

Modification(s)  
Name  Mukesh Kumar 
Designation   
Affiliation   
Address  Director- Clinical Operation & QA
KPS Clinical Services Pvt. Ltd.(CRO),F215,216, Neelkanth Plaza, Alpha-1
Not Applicable
N/A
201306
India 
Phone  01204231720  
Fax  01204213840  
Email  mukesh@kpsclin.com  
 
Source of Monetary or Material Support  
Naprod Life Science Pvt. Ltd. 304, town center Andheri- kurla Andheri (E)Mumbai 400059 
 
Primary Sponsor  
Name  Naprod Life Science Pvt. Ltd. 304, town center Andheri- kurla Andheri (E)Mumbai 400059 
Address   
Type of Sponsor   
 
Details of Secondary Sponsor  
Name  Address 
NIL   
 
Countries of Recruitment
Modification(s)  
  India  
Sites of Study
Modification(s)  
No of Sites = 3  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr. Rajeev Duggal  Jabalpur Hospital  Jabalpur Hospital,Russel chowk-
Jabalpur
MADHYA PRADESH 
9893173602

drrajeevd@rediffmail.com 
Dr. Balmiki Sharma  Primary Health Center  Medical officer incharge,Primary Health Center-852125

 


drbalmikisharma@gmail.com 
Dr Harendra Prasad Sahu  Sahu Clinic Raghopur  Raghopur,Dharbhanga, -851101
Darbhanga
BIHAR 
9472845675

drhpsahu@gmail.com 
 
Details of Ethics Committee
Modification(s)  
No of Ethics Committees= 2  
Name of Committee  Approval Status 
Hippocrates Independent Ethics Committee, Uttam Nagar, New Delhi-59  Approved 
Hippocrates Independent Ethics Committee, Uttam Nagar, New Delhi-59  Approved 
 
Regulatory Clearance Status from DCGI
Modification(s)  
Status 
Approved/Obtained 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  Surgery for lower abdomen or other lower extremities in male & Female patients,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Comparator Agent  Ketamine  75mg in 5% dextrose, with and without 1:200,000 epinephrine I.V. 
Intervention  s-ketamine  75mg in 5% dextrose, with and without 1:200,000 epinephrine I.V. 
 
Inclusion Criteria  
Age From   
Age To   
Gender   
Details  1.Patients(Male or Female) undergoing Surgeries for Lower Abdomen or other Lower Extremities 2.ASA GRADE I/II/III 3.Age between 30-60 years 4.Body mass index < 35 kg/m2  
 
ExclusionCriteria 
Details  1.Patients with respiratory, cardiac dieses, liver, kidney, neurological disorder 2.Diabetes , hypertension 3.Psychiatric disorder 4.Infection on back 5.Coagulation disorder ? Raised intracranial tension  
 
Method of Generating Random Sequence   Random Number Table 
Method of Concealment   Centralized 
Blinding/Masking   Participant, Investigator and Outcome Assessor Blinded 
Primary Outcome  
Outcome  TimePoints 
1.Postoperative abilities over time 2.Discharge time according to fixed criteria 3.Consumption of analgesics and anti emetics   1.Postoperative abilities over time 2.Discharge time according to fixed criteria 3.Consumption of analgesics and anti emetics  
 
Secondary Outcome  
Outcome  TimePoints 
1.Degree of nursing requirements 2.General tolerability of the regimes 3.Threshold for sensory perception and pain using the Pain Matcher device, pre- and postoperatively 4.A modified Bromage score should be used to measure motor block.   After the injection, followed by every 2 min for the first 15 min and every 5 min thereafter throughout the surgery and until the complete reversal of analgesia and motor blockade occurs. 
 
Target Sample Size
Modification(s)  
Total Sample Size="200"
Sample Size from India="200" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial
Modification(s)  
Phase 3 
Date of First Enrollment (India)
Modification(s)  
16/02/2011 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years=""
Months="2"
Days="0" 
Recruitment Status of Trial (Global)
Modification(s)  
Completed 
Recruitment Status of Trial (India)  Closed to Recruitment of Participants 
Publication Details    
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Brief Summary
Modification(s)  
This Study is a double blind randomized comparative controlled study of efficacy and duration of analgesia for Intrathecal Ketamine & S-Ketamine in Surgeries for Lower Abdomen or other Lower Extremities on 200 patients at three(3) sites in India. the primary outcomes & secondary outcomes are Primary Outcome Measures: 1.Postoperative abilities over time 2.Discharge time according to fixed criteria 3.Consumption of analgesics and anti emetics Secondary Outcome Measures: 4.Degree of nursing requirements 5.General tolerability of the regimes 6.Threshold for sensory perception and pain using the Pain Matcher device, pre- and postoperatively 7.A modified Bromage score should be used to measure motor block. 
Close